BAUM CHARLES M has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 9366 shares of Acrivon Therapeutics, Inc. ($ACRV) on May 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Acrivon Therapeutics, Inc. | $ACRV | BAUM CHARLES M | Not found | A | Common Stock | 9366 | $0.00 | 9,366.0000 | 38,560,464 | 9999.99% | 0.02% |
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | BAUM CHARLES M | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| June 5, 2025 | PMV Pharmaceuticals, Inc. | $PMVP | BAUM CHARLES M | Not found | A | Stock Option (right to buy) | 33500 | $0.00 | 33,500.0000 | 51,933,604 | 9999.99% | 0.06% |
| June 20, 2024 | Acrivon Therapeutics, Inc. | $ACRV | BAUM CHARLES M | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 22,078,190 | 9999.99% | 0.09% |
| June 6, 2024 | PMV Pharmaceuticals, Inc. | $PMVP | BAUM CHARLES M | Not found | A | Stock Option (right to buy) | 67500 | $0.00 | 67,500.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Acrivon Therapeutics, Inc. | $ACRV | BAUM CHARLES M | Not found | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | PMV Pharmaceuticals, Inc. | $PMVP | BAUM CHARLES M | Director | A | Stock Option (right to buy) | 21500 | $0.00 | 21,500.0000 | 0 | 9999.99% | 0.00% |